What's the Difference Between TB-500 and BPC-157, and Why Do People Take Them Together?

Two Popular Recovery Peptides

BPC-157 and TB-500 are two of the most talked-about peptides for injury recovery. They're often discussed together—and sometimes combined in what's called a "recovery stack." But they're different compounds with different proposed mechanisms.

What Is BPC-157?

BPC-157 is a synthetic peptide based on a protein found in stomach juice. Animal studies suggest it may support healing of tendons, ligaments, muscle, and the digestive tract, possibly by promoting blood vessel growth and reducing inflammation. (Read more in our article on whether BPC-157 works in humans.)

What Is TB-500?

TB-500 is a synthetic version of a fragment of thymosin beta-4, a protein naturally found in most human cells. Thymosin beta-4 plays a role in cell movement, blood vessel formation, and tissue repair. Animal studies suggest it may support healing of muscles, tendons, the heart, and skin.

Key Differences

• Origin: BPC-157 is derived from a stomach protein; TB-500 comes from a cell-repair protein
• Proposed focus: BPC-157 is often discussed for tendons, ligaments, and gut health; TB-500 for muscle, flexibility, and broader tissue repair
• Mechanism: Both may promote blood vessel growth, but through different pathways

Why Do People Combine Them?

The theory is that because they may work through different mechanisms, combining them could support recovery more broadly. However, there are no human clinical trials testing them together, and very little human research on either one alone.

Safety Considerations

• Human safety data for both is very limited
• Both may promote blood vessel growth, raising theoretical concerns for people with cancer
• Online "research peptides" are unregulated and may be impure or mislabeled
• Both are prohibited by the World Anti-Doping Agency for competitive athletes

Regulatory Status

Neither peptide is FDA-approved. In October 2026, HHS announced an interim policy allowing licensed pharmacies to compound both under specific conditions while FDA rulemaking is pending. This is not FDA approval. Peptide regulations have changed several times in 2026, so a provider can help you understand current rules.

If you're interested in recovery peptides, talk with a provider first: Talk to a Heva Specialist

The Bottom Line

TB-500 and BPC-157 are different peptides that may support healing through different pathways, which is why they're often combined. But the evidence is mostly from animals, so they should be approached with caution and medical guidance.